AnalystBook Research · Company Intelligence

AmpliTech Group, Inc.

AMPGNasdaq

Built from AmpliTech Group, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

AmpliTech revenue rose 165.0% to $25.2M, while the net loss narrowed to $7.0M and free cash flow stayed negative.

The read at a glance✓ Audited against SEC data
  • Business mixRF amplifiers and microwave componentsNote
  • RevenueRevenue rose 165.0% to $25.2MOK
  • ProfitabilityNet loss narrowed 37.7%OK
  • CashFree cash flow was -$9.7MWatch
  • Balance sheetEquity fell 12.3%Watch
  • Insiders1 buy / 0 sellsNote
  • AccountingAltman-Z distress; EQ safeWatch

Business

AmpliTech designs, engineers, and assembles microwave component-based amplifiers and related RF subsystems for satellite communications, telecom, space, defense, quantum computing, and other high-frequency uses.

Where the revenue comes from

Fiscal 2025, as AmpliTech Group, Inc. reports it. History and quarterly detail are in the app.

  • Manufacturing And Engineering$17.0M
  • Distribution$8.2M
  • Corporates$33K

Leadership changes

From AmpliTech Group, Inc.'s own filings, the day they're filed.

  • Matthew Kappers · chairman · departure

Latest filings

  • 8-K · Company announcement2026-08-17
  • 8-K · Company announcement2026-08-13
  • 10-Q · Quarterly report2026-08-13
  • 8-K · Company announcement2026-08-12
  • 8-K · Company announcement2026-07-22
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about AmpliTech Group, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.